167 related articles for article (PubMed ID: 12766165)
1. Fluorescence resonance energy transfer analysis of cytochromes P450 2C2 and 2E1 molecular interactions in living cells.
Szczesna-Skorupa E; Mallah B; Kemper B
J Biol Chem; 2003 Aug; 278(33):31269-76. PubMed ID: 12766165
[TBL] [Abstract][Full Text] [Related]
2. Bimolecular fluorescence complementation analysis of cytochrome p450 2c2, 2e1, and NADPH-cytochrome p450 reductase molecular interactions in living cells.
Ozalp C; Szczesna-Skorupa E; Kemper B
Drug Metab Dispos; 2005 Sep; 33(9):1382-90. PubMed ID: 15980100
[TBL] [Abstract][Full Text] [Related]
3. Cytochromes P450 2C1/2 and P450 2E1 are retained in the endoplasmic reticulum membrane by different mechanisms.
Szczesna-Skorupa E; Chen CD; Kemper B
Arch Biochem Biophys; 2000 Feb; 374(2):128-36. PubMed ID: 10666290
[TBL] [Abstract][Full Text] [Related]
4. BAP31 is involved in the retention of cytochrome P450 2C2 in the endoplasmic reticulum.
Szczesna-Skorupa E; Kemper B
J Biol Chem; 2006 Feb; 281(7):4142-8. PubMed ID: 16332681
[TBL] [Abstract][Full Text] [Related]
5. Mobility of cytochrome P450 in the endoplasmic reticulum membrane.
Szczesna-Skorupa E; Chen CD; Rogers S; Kemper B
Proc Natl Acad Sci U S A; 1998 Dec; 95(25):14793-8. PubMed ID: 9843968
[TBL] [Abstract][Full Text] [Related]
6. The cytoplasmic and N-terminal transmembrane domains of cytochrome P450 contain independent signals for retention in the endoplasmic reticulum.
Szczesna-Skorupa E; Ahn K; Chen CD; Doray B; Kemper B
J Biol Chem; 1995 Oct; 270(41):24327-33. PubMed ID: 7592644
[TBL] [Abstract][Full Text] [Related]
7. Substitutions in the C-terminal portion of the catalytic domain partially reverse assembly defects introduced by mutations in the N-terminal linker sequence of cytochrome P450 2C2.
Doray B; Chen CD; Kemper B
Biochemistry; 1999 Sep; 38(37):12180-6. PubMed ID: 10508423
[TBL] [Abstract][Full Text] [Related]
8. Proteasome inhibition compromises direct retention of cytochrome P450 2C2 in the endoplasmic reticulum.
Szczesna-Skorupa E; Kemper B
Exp Cell Res; 2008 Oct; 314(17):3221-31. PubMed ID: 18755184
[TBL] [Abstract][Full Text] [Related]
9. Competitive interactions between cytochromes P450 2A6 and 2E1 for NADPH-cytochrome P450 oxidoreductase in the microsomal membranes produced by a baculovirus expression system.
Tan Y; Patten CJ; Smith T; Yang CS
Arch Biochem Biophys; 1997 Jun; 342(1):82-91. PubMed ID: 9185616
[TBL] [Abstract][Full Text] [Related]
10. Identification by in vitro mutagenesis of the interaction of two segments of C2MstC1, a chimera of cytochromes P450 2C2 and P450 2C1.
Ramarao MK; Straub P; Kemper B
J Biol Chem; 1995 Jan; 270(4):1873-80. PubMed ID: 7829524
[TBL] [Abstract][Full Text] [Related]
11. Bax inhibitor 1 regulates ER-stress-induced ROS accumulation through the regulation of cytochrome P450 2E1.
Kim HR; Lee GH; Cho EY; Chae SW; Ahn T; Chae HJ
J Cell Sci; 2009 Apr; 122(Pt 8):1126-33. PubMed ID: 19339548
[TBL] [Abstract][Full Text] [Related]
12. Organization of multiple cytochrome P450s with NADPH-cytochrome P450 reductase in membranes.
Backes WL; Kelley RW
Pharmacol Ther; 2003 May; 98(2):221-33. PubMed ID: 12725870
[TBL] [Abstract][Full Text] [Related]
13. Requirements for cytochrome b5 in the oxidation of 7-ethoxycoumarin, chlorzoxazone, aniline, and N-nitrosodimethylamine by recombinant cytochrome P450 2E1 and by human liver microsomes.
Yamazaki H; Nakano M; Gillam EM; Bell LC; Guengerich FP; Shimada T
Biochem Pharmacol; 1996 Jul; 52(2):301-9. PubMed ID: 8694855
[TBL] [Abstract][Full Text] [Related]
14. P450BM-3; a tale of two domains--or is it three?
Peterson JA; Sevrioukova I; Truan G; Graham-Lorence SE
Steroids; 1997 Jan; 62(1):117-23. PubMed ID: 9029725
[TBL] [Abstract][Full Text] [Related]
15. A conserved proline-rich sequence between the N-terminal signal-anchor and catalytic domains is required for assembly of functional cytochrome P450 2C2.
Chen CD; Doray B; Kemper B
Arch Biochem Biophys; 1998 Feb; 350(2):233-8. PubMed ID: 9473296
[TBL] [Abstract][Full Text] [Related]
16. Interactions of mammalian cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b(5) enzymes.
Shimada T; Mernaugh RL; Guengerich FP
Arch Biochem Biophys; 2005 Mar; 435(1):207-16. PubMed ID: 15680923
[TBL] [Abstract][Full Text] [Related]
17. Deletion of a conserved tetrapeptide, PPGP, in P450 2C2 results in loss of enzymatic activity without a change in its cellular location.
Szczesna-Skorupa E; Straub P; Kemper B
Arch Biochem Biophys; 1993 Jul; 304(1):170-5. PubMed ID: 8323283
[TBL] [Abstract][Full Text] [Related]
18. N-terminal deletions and His-tag fusions dramatically affect expression of cytochrome p450 2C2 in bacteria.
Doray B; Chen CD; Kemper B
Arch Biochem Biophys; 2001 Sep; 393(1):143-53. PubMed ID: 11516171
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Interactions Among CYP1A2, CYP2B4, and NADPH-cytochrome P450 Reductase: Identification of Specific Protein Complexes.
Connick JP; Reed JR; Backes WL
Drug Metab Dispos; 2018 Mar; 46(3):197-203. PubMed ID: 29233819
[TBL] [Abstract][Full Text] [Related]
20. Human enzymes involved in the metabolic activation of the environmental contaminant 3-nitrobenzanthrone: evidence for reductive activation by human NADPH:cytochrome p450 reductase.
Arlt VM; Stiborova M; Hewer A; Schmeiser HH; Phillips DH
Cancer Res; 2003 Jun; 63(11):2752-61. PubMed ID: 12782579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
